JACKSONVILLE, Fla., Sept. 01, 2022 (GLOBE NEWSWIRE) — Triall, a blockchain-integrated eClinical platform provider, has collaborated with researchers at Mayo Clinic to advance clinical trial design and management of study data. This collaboration takes an important next step towards leading a global transformation towards decentralized clinical research.
Triall’s eClinical platform will support a 2-year multi-center pulmonary arterial hypertension trial that includes 10 research sites* and 500+ patients across the United States, starting in September of this year. The eClinical solutions of Triall will support all core trial activities, including data capture, document management, study monitoring, and eConsent.
The collaboration takes a unique angle by demonstrating how Triall’s Verifiable Proof API can be applied to build immutable blockchain-registered audit trails as a new best practice for bolstering clinical data integrity ‘end-to-end’—from study start-up to study close-out and post-study activities. With more data being collected from an increasing number and variety of systems and devices, assuring data integrity is a growing concern for clinical trial stakeholders, and a major barrier to reliable and efficient medical research in the digital age.
The audit trail will offer a system-independent interface for investigators, monitors, IRBs, regulators, and other trial stakeholders to rapidly evaluate the existence and integrity of trial-related…